[2] Schrag SJ, Verani JR, Dixon BE, et al. Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of delta and omicron variant predominance in the United States....
四川大学华西医院李为民/陈蕾/刘丹团队在知名期刊Signal Transduction and Targeted Therapy(IF= 39.3,JCR分区一区)在线发表题为“Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vacci...
In this section, we introduce the components and the trial efficacies of the vaccines. It should be noted that efficacy refers to vaccine performance in controlled trials, whereas effectiveness is drawn from real-world observations. Vaccine efficacies cannot be readily compared because the efficacy can...
Johnson & Johnson on Friday said its single-dose vaccine was 72 percent effective in preventing COVID-19 in the United States but a lower rate of 66 percent was observed globally in the large trial conducted across three continents and against multiple variants. In the trial of ...
VACCINE effectivenessCOVID-19 vaccinesIntroduction: Currently there is no recommendation for testing post vaccination COVID antibody levels, however with repeated COVID waves it is important to evaluate post vaccination COVID antibody levels specifically among Health Care Workers. Methods: This...
Although severe COVID-19 in children is rare, they may develop multisystem inflammatory syndrome, long-COVID and downstream effects of COVID-19, including social isolation and disruption of education. Data on the effectiveness of the CoronaVac vaccine is
3）vaccine effectiveness（疫苗保护能力）——接种1剂后对感染的有效性降低;接种2剂后感染率减少；——对医疗系统包括有实际效果；——加拿大的大部分德尔塔病例患者是未接种或未完全接种者 需要两剂疫苗来对包括德尔塔病毒在内的变异病毒进行强有力的保护 超过81%的符合条件的12岁及以上的人 至少接种一剂COVID-19...
COVID-19 vaccine trackerand landscape. (n.d.). Retrieved June6, 2021, fromhttps://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines Landscape ofobservational study designs on the effectiveness of COVID-19 vaccination.(n.d.). Retrieved June 6, 2021, fromhttps:...
vaccine protection (efficacy/effectiveness) shows considerable difference (ANOVA testP < 0.001; Fig.1a). The mRNA vaccines reported the highest mean VE of 90.0% (95% confidence interval (CI): 88.2–91.8,n = 39), followed by the protein subunit vaccine (82.9%) (95% CI: 67.0–98....
Dr. Jödicke commented, "We are very excited to see that the Norwegian vaccine effectiveness results are supporting our previous findings of a reduction in risk of long COVID, and post-COVID cardiac and thromboembolic complications." Trinh, Researcher at PharmaSafe research group, at the Univer...